India promises more compulsory licences
Natco licence confirmed
Government report says prices too high
Three cancer drugs up next
It keeps getting worse for patent owners in India. Last month the IP Appellate Board upheld the compulsory licence issued to Natco over a Bayer drug, Nexavar, and then...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.